Anavex Life Sciences Corp (AVXL)

[ignatiusrielly35]

Of course the EMA has not reviewed the data. They reviewed the top line results and greenlit an application. And, as Boi noted, and sourced, at that point the majority of drugs are then ultimately approved. As someone else sourced well, the EU policy makers have recently concluded that an aggressive approach must be taken with regard to Alzheimer’s treatments. This is all cause for some optimism.